Dupixent shows potential as a treatment for atopic dermatitis, alopecia and vitiligo, targeting shared immune pathways for ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 1 clinical trial titled ‘A PHASE 1, ...

Incyte Corporation (($CC:INCY.CUR)) announced an update on their ongoing clinical study. Incyte Corporation is conducting a Phase 3b clinical ...

Jiangsu Vcare Pharmatech Co., Ltd. (Jiangsu Vcare) announced that it has entered into an exclusive strategic partnership with ...

For patients with skin of color and atopic dermatitis (AD), lebrikizumab is efficacious and safe, according to a study ...

Severe atopic dermatitis affects at least 30 percent of the body. The size of your child’s palm is about 1 percent, he explains, so if there are 10 areas the size of their palm affected, your ...

Integrative approaches targeting neurological and immune pathways may help break the itch–scratch cycle in atopic dermatitis, improving pruritus, stress, sleep, and patient outcomes.

The prevalence of atopic dermatitis is estimated to be from 10% to 20%. Most people are using the figures from 13% to 15% in the United States.

Answer: Atopic dermatitis is a very common skin disease found in both adults and children. In fact, up to 10 to 20 percent of the population at some point suffers from atopic dermatitis.

Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985-2010. PLoS One. 2011;6 (4):e17520. doi: 10.1371/journal.pone ...

There’s no single test for diagnosing atopic dermatitis (eczema). Rather, your dermatologist will likely examine your skin, ask about your symptoms, and possibly run a couple tests.

Atopic dermatitis as a type of eczema that appears as itchy patches of dry skin. These patchy lesions typically pop up on the arms and the backs of the legs, with colors ranging between red and ...